Management of Treatment-Experienced HIV-Infected Patients

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/21 (What's New)

Summary

  • HIV-infected patients needing to modify treatment due to virologic failure have several highly active and well-tolerated options
  • First step in optimizing treatment is defining potential obstacles to success, such as factors associated with poor treatment adherence[Chesney 2006]
  • Selecting a new regimen requires determining which agents are likely to be virologically active for a given patient and using them in effective combinations

Action required

Keywords: Management of Treatment-Experienced Patients, Resistance Testing

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.